Supplementary Figure S7 from Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies
Year: 2024
Type: supplementary-materials
Abstract: Supplemental Figure 7. Quantification of immune cell composition in selected tumors determined by immunofluorescence multi-plex assay.
Language: English
Topic: Bacterial Cancer Therapy
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4402803974
Cites:
Cited by:
Related to: